ADA (Adenosine Deaminase) deficiency leads to severe immune system dysfunction.
Repeated infusions of genetically engineered lymphocytes temporarily restore immune function.
Permanent Remedy: Gene therapy to introduce a functional ADA gene into the patient's bone marrow cells, ensuring lifelong enzyme production.